PDS Biotechnology Corp Files 8-K on Financials

Ticker: PDSB · Form: 8-K · Filed: Mar 27, 2025 · CIK: 1472091

Pds Biotechnology Corp 8-K Filing Summary
FieldDetail
CompanyPds Biotechnology Corp (PDSB)
Form Type8-K
Filed DateMar 27, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, operations, company-update

TL;DR

PDS Biotech dropped an 8-K on 3/27 detailing financials and operations.

AI Summary

PDS Biotechnology Corporation filed an 8-K on March 27, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing details the company's status as a pharmaceutical preparations company incorporated in Delaware with its principal executive offices in Princeton, NJ.

Why It Matters

This filing provides crucial updates on PDS Biotechnology's financial health and operational results, which are essential for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial filing (8-K) and does not contain specific news that would immediately impact risk.

Key Numbers

  • 001-37568 — SEC File Number (Identifies the company's filing with the SEC.)
  • 26-4231384 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

  • PDS Biotechnology Corporation (company) — Registrant
  • March 27, 2025 (date) — Date of Report
  • Delaware (jurisdiction) — State of Incorporation
  • Princeton, NJ (location) — Principal Executive Offices
  • Edge Therapeutics, Inc. (company) — Former Company Name

FAQ

What specific financial results or operational updates are detailed in this 8-K filing?

The filing indicates it covers 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but the specific details are not provided in the provided text.

When was PDS Biotechnology Corporation incorporated, and in which state?

PDS Biotechnology Corporation was incorporated in Delaware.

What is the address of PDS Biotechnology Corporation's principal executive offices?

The principal executive offices are located at 303A College Road East, Princeton, NJ 08540.

Has PDS Biotechnology Corporation undergone any name changes?

Yes, the company was formerly known as Edge Therapeutics, Inc., with a date of name change on September 11, 2009.

What is the SIC code for PDS Biotechnology Corporation?

The Standard Industrial Classification (SIC) code for PDS Biotechnology Corporation is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 27, 2025 regarding PDS Biotechnology Corp (PDSB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.